AC Immune S.A.

AC Immune S.A.verified

ACIU

Price:

$2.88

Market Cap:

$232.66M

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease (AD). It is also developing ACI-24, an anti-Abeta vaccine candidate that is ...[Read more]

Industry

Biotechnology

IPO Date

2016-09-23

Stock Exchange

NASDAQ

Ticker

ACIU

The Enterprise Value as of December 2025 (TTM) for AC Immune S.A. (ACIU) is 211.85M

According to AC Immune S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 211.85M. This represents a change of -0.74% compared to the average of 213.43M of the last 4 quarters.

AC Immune S.A. (ACIU) Historical Enterprise Value (quarterly & annually)

How has ACIU Enterprise Value performed in the past?

The mean historical Enterprise Value of AC Immune S.A. over the last ten years is 378.09M. The current 211.85M Enterprise Value has changed 5.50% with respect to the historical average. Over the past ten years (40 quarters), ACIU's Enterprise Value was at its highest in in the December 2015 quarter at 790.51M. The Enterprise Value was at its lowest in in the March 2023 quarter at 124.27M.

Quarterly (TTM)
Annual

Average

378.09M

Median

336.07M

Minimum

128.74M

Maximum

790.51M

AC Immune S.A. (ACIU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AC Immune S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 118.31%

Maximum Annual Enterprise Value = 790.51M

Minimum Annual Increase = -56.40%

Minimum Annual Enterprise Value = 128.74M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024213.49M-24.04%
2023281.04M118.31%
2022128.74M-50.28%
2021258.93M51.85%
2020170.52M-56.40%
2019391.09M-6.66%
2018418.99M-32.21%
2017618.07M21.31%
2016509.49M-35.55%
2015790.51M-7.95%

AC Immune S.A. (ACIU) Average Enterprise Value

How has ACIU Enterprise Value performed in the past?

The current Enterprise Value of AC Immune S.A. (ACIU) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

207.76M

5-year avg

210.54M

10-year avg

378.09M

AC Immune S.A. (ACIU) Enterprise Value vs. Peers

How is ACIU’s Enterprise Value compared to its peers?

AC Immune S.A.’s Enterprise Value is less than Aldeyra Therapeutics, Inc. (267.81M), less than Cellectis S.A. (394.17M), less than Alto Neuroscience, Inc. (272.30M), less than Silence Therapeutics plc (254.57M), less than Amarin Corporation plc (224.37M), less than Contineum Therapeutics, Inc. Class A Common Stock (283.26M), less than Lyell Immunopharma, Inc. (488.00M), less than Mereo BioPharma Group plc (270.19M), less than Annexon, Inc. (432.32M), less than Alpha Tau Medical Ltd. (356.31M),

Build a custom stock screener for AC Immune S.A. (ACIU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AC Immune S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AC Immune S.A. (ACIU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AC Immune S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AC Immune S.A.'s Enterprise Value?

What is the highest Enterprise Value for AC Immune S.A. (ACIU)?

What is the 3-year average Enterprise Value for AC Immune S.A. (ACIU)?

What is the 5-year average Enterprise Value for AC Immune S.A. (ACIU)?

How does the current Enterprise Value for AC Immune S.A. (ACIU) compare to its historical average?